Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

New evidence shows that GLP-1 drugs might be more effective than aspirin at preventing colorectal cancer, while also ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.

Your family’s history of cancer suggests a genetic component. Among genetically vulnerable individuals, low-dose aspirin ...

President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical guidelines and ...

Q. I’m 76 years old, and I’ve taken an aspirin every day since I was 28 because of arthritis. Although cancer runs in my family on both sides, I’ve never had cancer of any sort.My dad died of prostate ...

Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...

A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...